- Report
- January 2025
- 185 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- November 2024
- 183 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- September 2025
- 276 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 377 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 191 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 389 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 376 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 588 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 282 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 196 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 474 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 413 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- December 2024
- 200 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- January 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- May 2025
- 154 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- May 2025
- 115 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- October 2024
- 200 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- October 2024
- 200 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- December 2024
- 200 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- December 2024
- 146 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more